{
    "hands_on_practices": [
        {
            "introduction": "The intricate hormonal dialogue between theca and granulosa cells is the cornerstone of follicular steroidogenesis, a process elegantly described by the two-cell, two-gonadotropin model. This exercise provides a practical application of this model by using Michaelis-Menten kinetics to quantify estradiol production. By calculating the rate of estradiol synthesis under baseline conditions and in response to hypothetical interventions, you will gain a deeper understanding of how substrate availability and enzyme activity are critical control points in hormone production. ",
            "id": "4481777",
            "problem": "A patient in the late follicular, preovulatory phase has a dominant follicle with granulosa cells primed by Follicle-Stimulating Hormone (FSH) and theca cells responsive to Luteinizing Hormone (LH). According to the two-cell, two-gonadotropin model, LH drives androgen synthesis in theca cells, and FSH induces aromatase (cytochrome P450 family 19 subfamily A member 1, CYP19A1) in granulosa cells to convert androgens to estradiol. Assume, for the preovulatory dominant follicle, that immediate (minutes to approximately $60$ minutes) changes in serum estradiol reflect changes in granulosa aromatase-mediated estradiol production, with gonadotropins approximately constant on this timescale and clearance unchanged.\n\nLet granulosa aromatase follow Michaelis–Menten kinetics: the instantaneous estradiol production rate is modeled as\n$$v = \\dfrac{V_{\\max}\\,[A]}{K_m + [A]}$$,\nwhere $[A]$ is intrafollicular androgen concentration available to granulosa cells, $V_{\\max}$ is the maximal rate reflecting aromatase enzyme capacity under FSH stimulation, and $K_m$ is the Michaelis constant.\n\nBaseline parameters just prior to the natural Luteinizing Hormone (LH) surge are:\n- $V_{\\max} = 100$ arbitrary units per hour,\n- $K_m = 10$ arbitrary units of $[A]$,\n- $[A] = 10$ arbitrary units.\n\nTwo acute interventions are considered:\n1) An intravenous bolus of exogenous androgen raises $[A]$ rapidly to $40$ arbitrary units without altering $V_{\\max}$ or $K_m$ over the next $30$ minutes.\n2) A rapid-onset aromatase inhibitor reduces $V_{\\max}$ to $20$ arbitrary units per hour within $30$ minutes and does not acutely change $K_m$ or $[A]$.\n\nWhich option best predicts the immediate direction and approximate magnitude of change in estradiol production rate $v$ under each intervention, based on the two-cell model and enzyme kinetics?\n\nA. Exogenous androgen increases $v$ from approximately $50$ to approximately $80$ units/hour; aromatase inhibition decreases $v$ to approximately $10$ units/hour.\n\nB. Exogenous androgen decreases $v$ to approximately $20$ units/hour by suppressing aromatase; aromatase inhibition increases $v$ to approximately $90$ units/hour by diverting substrate.\n\nC. Neither intervention acutely changes $v$ because gonadotropin feedback dominates on minute-to-hour timescales.\n\nD. Both interventions modestly increase $v$ because intrafollicular androgen availability rises in each case.",
            "solution": "## Problem Validation\n\n### Step 1: Extract Givens\n\nThe problem provides the following information:\n- **System:** A dominant follicle in the late follicular, preovulatory phase.\n- **Model:** The two-cell, two-gonadotropin model, where Luteinizing Hormone (LH) drives theca cell androgen synthesis and Follicle-Stimulating Hormone (FSH) induces granulosa cell aromatase (CYP19A1) to convert androgens to estradiol.\n- **Kinetics:** The instantaneous estradiol production rate, $v$, is modeled by the Michaelis–Menten equation:\n$$v = \\dfrac{V_{\\max}\\,[A]}{K_m + [A]}$$\nwhere $[A]$ is intrafollicular androgen concentration, $V_{\\max}$ is the maximal rate, and $K_m$ is the Michaelis constant.\n- **Assumptions:**\n    - Immediate changes (minutes to approximately $60$ minutes) in serum estradiol reflect changes in $v$.\n    - Gonadotropins are approximately constant on this timescale.\n    - Estradiol clearance is unchanged.\n- **Baseline Parameters:**\n    - $V_{\\max} = 100$ arbitrary units per hour\n    - $K_m = 10$ arbitrary units of $[A]$\n    - $[A] = 10$ arbitrary units\n- **Intervention 1 (Exogenous Androgen):**\n    - $[A]$ is raised to $40$ arbitrary units.\n    - $V_{\\max}$ and $K_m$ are unchanged over the next $30$ minutes.\n- **Intervention 2 (Aromatase Inhibitor):**\n    - $V_{\\max}$ is reduced to $20$ arbitrary units per hour.\n    - $K_m$ and $[A]$ are not acutely changed.\n- **Question:** Predict the immediate direction and approximate magnitude of change in estradiol production rate $v$ for each intervention.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem statement is evaluated against the validation criteria:\n\n- **Scientifically Grounded:** The problem is based on the established two-cell, two-gonadotropin model of ovarian steroidogenesis, a fundamental concept in reproductive endocrinology. The use of Michaelis-Menten kinetics to model enzyme (aromatase) activity is a standard and appropriate biochemical approach. The proposed interventions—increasing substrate availability and inhibiting enzyme activity—are classic methods for probing enzyme-catalyzed reactions and are conceptually sound.\n- **Well-Posed:** All necessary parameters for the kinetic model ($V_{\\max}$, $K_m$, and $[A]$) are provided for a baseline state and for two distinct, well-defined interventions. The question asks for a quantitative prediction based on the provided model and data, which allows for a unique, calculable solution.\n- **Objective:** The problem is stated in precise, quantitative, and unbiased language. The use of \"arbitrary units\" properly abstracts the problem to focus on the kinetic relationships rather than debating specific physiological concentrations, which can vary widely.\n- **Consistency and Completeness:** The problem is self-contained. The assumptions (e.g., constant gonadotropins on a short timescale) are explicitly stated to define the boundaries of the model, preventing ambiguity. There are no contradictions in the provided data or conditions.\n\n### Step 3: Verdict and Action\n\nThe problem is **valid**. It is a well-posed, scientifically grounded application of enzyme kinetics to a core physiological process. The solution can now be derived.\n\n## Solution Derivation\n\nThe solution requires applying the provided Michaelis-Menten equation under three conditions: baseline, Intervention 1, and Intervention 2.\n\nThe governing equation is:\n$$v = \\dfrac{V_{\\max}\\,[A]}{K_m + [A]}$$\n\n**1. Baseline Estradiol Production Rate ($v_{baseline}$)**\n\nUsing the baseline parameters:\n- $V_{\\max} = 100$\n- $K_m = 10$\n- $[A] = 10$\n\nWe calculate the initial rate $v_{baseline}$:\n$$v_{baseline} = \\dfrac{(100) \\cdot (10)}{10 + 10} = \\dfrac{1000}{20} = 50 \\text{ arbitrary units per hour}$$\nAt baseline, the androgen concentration $[A]$ is equal to the Michaelis constant $K_m$. This indicates that the aromatase enzyme is operating at exactly half of its maximal velocity ($v = V_{\\max}/2$).\n\n**2. Production Rate under Intervention 1 (Exogenous Androgen)**\n\nIn this scenario, the androgen substrate concentration is increased. The parameters are:\n- $V_{\\max} = 100$ (unchanged)\n- $K_m = 10$ (unchanged)\n- $[A] = 40$ (increased)\n\nWe calculate the new rate, which we'll call $v_1$:\n$$v_1 = \\dfrac{(100) \\cdot (40)}{10 + 40} = \\dfrac{4000}{50} = 80 \\text{ arbitrary units per hour}$$\nThus, the exogenous androgen bolus increases the estradiol production rate from $50$ to $80$ arbitrary units per hour.\n\n**3. Production Rate under Intervention 2 (Aromatase Inhibitor)**\n\nIn this scenario, the effective concentration of the enzyme is reduced, which is modeled as a decrease in $V_{\\max}$. This represents a non-competitive or irreversible inhibitor model over this short time frame. The parameters are:\n- $V_{\\max} = 20$ (reduced)\n- $K_m = 10$ (unchanged)\n- $[A] = 10$ (unchanged)\n\nWe calculate the new rate, which we'll call $v_2$:\n$$v_2 = \\dfrac{(20) \\cdot (10)}{10 + 10} = \\dfrac{200}{20} = 10 \\text{ arbitrary units per hour}$$\nThus, the aromatase inhibitor decreases the estradiol production rate from $50$ to $10$ arbitrary units per hour.\n\n## Option-by-Option Analysis\n\n**A. Exogenous androgen increases $v$ from approximately $50$ to approximately $80$ units/hour; aromatase inhibition decreases $v$ to approximately $10$ units/hour.**\n- Our calculation for Intervention 1 shows that $v$ increases from a baseline of $50$ to $80$ units/hour. This matches the first part of the option.\n- Our calculation for Intervention 2 shows that $v$ decreases from a baseline of $50$ to $10$ units/hour. This matches the second part of the option.\n- The results are quantitatively and directionally correct.\n**Verdict: Correct.**\n\n**B. Exogenous androgen decreases $v$ to approximately $20$ units/hour by suppressing aromatase; aromatase inhibition increases $v$ to approximately $90$ units/hour by diverting substrate.**\n- The first claim is incorrect. Increasing the concentration of the substrate a reaction is dependent on will increase the reaction rate, not decrease it, until saturation is reached. Our calculation shows an increase to $80$ units/hour.\n- The second claim is incorrect. An aromatase inhibitor, by definition, inhibits aromatase, which decreases estradiol production. The idea that this would increase production is contradictory. Our calculation shows a decrease to $10$ units/hour.\n**Verdict: Incorrect.**\n\n**C. Neither intervention acutely changes $v$ because gonadotropin feedback dominates on minute-to-hour timescales.**\n- This contradicts the premises of the problem, which explicitly state to assume gonadotropins are constant and to evaluate the immediate effects on the kinetic system. Furthermore, our calculations show substantial acute changes in $v$.\n**Verdict: Incorrect.**\n\n**D. Both interventions modestly increase $v$ because intrafollicular androgen availability rises in each case.**\n- This statement contains two errors. First, Intervention 2 (aromatase inhibition) causes a significant decrease in $v$, not an increase. Second, the premise that androgen availability rises in each case is false; the problem explicitly states that for Intervention 2, $[A]$ \"does not acutely change\".\n**Verdict: Incorrect.**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "The resumption of meiosis in the oocyte, marked by Germinal Vesicle Breakdown (GVBD), is a precisely timed event triggered by the Luteinizing Hormone (LH) surge. This critical step from meiotic arrest to a fertilizable state is orchestrated by a complex intracellular signaling cascade. This problem allows you to model a key part of this cascade by treating the decay of the inhibitory second messenger, cyclic guanosine monophosphate (cGMP), as a first-order kinetic process, thereby calculating the exact timing of this fundamental event in reproductive biology. ",
            "id": "4481795",
            "problem": "In the mammalian preovulatory follicle, granulosa and cumulus cells maintain high cyclic adenosine monophosphate (cAMP) in the oocyte via intercellular transfer of cyclic guanosine monophosphate (cGMP), which inhibits phosphodiesterase 3A (PDE3A) in the oocyte. Following the luteinizing hormone (LH) surge, epidermal growth factor (EGF) network signaling and gap junction closure reduce cGMP supply and activate cGMP hydrolysis, allowing cAMP to fall and M-phase promoting factor (MPF) to be activated, culminating in germinal vesicle breakdown (GVBD). Assume that immediately after the LH surge at time $t=0$, the oocyte cGMP concentration $c(t)$ obeys first-order decay kinetics due to phosphodiesterase activity with a constant rate $k$, that is, $\\frac{dc}{dt}=-k\\,c$, with initial condition $c(0)=c_0$. GVBD is initiated when the cGMP concentration reaches a threshold $c_{\\mathrm{thr}}$ such that $0<c_{\\mathrm{thr}}<c_0$.\n\nStarting from the stated kinetic law and initial condition, derive a closed-form analytic expression for the time to germinal vesicle breakdown, $t_{\\mathrm{GVBD}}$, defined by $c(t_{\\mathrm{GVBD}})=c_{\\mathrm{thr}}$, in terms of $k$, $c_0$, and $c_{\\mathrm{thr}}$. Express the time in minutes, assuming $k$ is measured in $\\text{min}^{-1}$. Your final answer must be a single closed-form expression.",
            "solution": "The problem statement is scientifically sound, well-posed, and provides all necessary information to derive a unique solution. The biological context describes the hormonal and intracellular signaling cascade that triggers the resumption of meiosis in a mammalian oocyte, a process known as germinal vesicle breakdown (GVBD). The mathematical model provided is a first-order kinetic decay for the concentration of cyclic guanosine monophosphate (cGMP), denoted by $c(t)$, following the luteinizing hormone (LH) surge at time $t=0$.\n\nThe governing ordinary differential equation is:\n$$\n\\frac{dc}{dt} = -k\\,c\n$$\nwhere $k$ is the constant rate of cGMP hydrolysis, and $c(t)$ is the cGMP concentration at time $t$. The initial condition is given as:\n$$\nc(0) = c_0\n$$\nThis is a first-order linear homogeneous differential equation, which can be solved by the method of separation of variables. We rearrange the equation to separate the variables $c$ and $t$:\n$$\n\\frac{1}{c} dc = -k \\, dt\n$$\nNext, we integrate both sides of the equation. The integration is performed from the initial state at time $t=0$ to an arbitrary state at time $t$.\n$$\n\\int_{c(0)}^{c(t)} \\frac{1}{c'} dc' = \\int_{0}^{t} -k \\, dt'\n$$\nThe integral of $\\frac{1}{c'}$ is $\\ln|c'|$. Since concentration must be non-negative, we can omit the absolute value. Evaluating the definite integrals yields:\n$$\n[\\ln(c')]_{c(0)}^{c(t)} = [-k t']_{0}^{t}\n$$\n$$\n\\ln(c(t)) - \\ln(c(0)) = -k t - (-k \\cdot 0)\n$$\nUsing the property of logarithms $\\ln(a) - \\ln(b) = \\ln(a/b)$, we have:\n$$\n\\ln\\left(\\frac{c(t)}{c(0)}\\right) = -k t\n$$\nSubstituting the initial condition $c(0) = c_0$:\n$$\n\\ln\\left(\\frac{c(t)}{c_0}\\right) = -k t\n$$\nTo find the explicit form of $c(t)$, we exponentiate both sides:\n$$\n\\frac{c(t)}{c_0} = \\exp(-k t)\n$$\n$$\nc(t) = c_0 \\exp(-k t)\n$$\nThis equation describes the exponential decay of cGMP concentration in the oocyte over time.\n\nGerminal vesicle breakdown (GVBD) is initiated at a specific time, $t_{\\mathrm{GVBD}}$, when the cGMP concentration drops to a threshold value, $c_{\\mathrm{thr}}$. This condition is expressed as:\n$$\nc(t_{\\mathrm{GVBD}}) = c_{\\mathrm{thr}}\n$$\nWe substitute $t = t_{\\mathrm{GVBD}}$ into our solution for $c(t)$ and set it equal to $c_{\\mathrm{thr}}$:\n$$\nc_0 \\exp(-k t_{\\mathrm{GVBD}}) = c_{\\mathrm{thr}}\n$$\nOur goal is to solve for $t_{\\mathrm{GVBD}}$. We begin by isolating the exponential term:\n$$\n\\exp(-k t_{\\mathrm_{\\mathrm{GVBD}}}) = \\frac{c_{\\mathrm{thr}}}{c_0}\n$$\nTo solve for the exponent, we take the natural logarithm of both sides:\n$$\n\\ln\\left(\\exp(-k t_{\\mathrm{GVBD}})\\right) = \\ln\\left(\\frac{c_{\\mathrm{thr}}}{c_0}\\right)\n$$\n$$\n-k t_{\\mathrm{GVBD}} = \\ln\\left(\\frac{c_{\\mathrm{thr}}}{c_0}\\right)\n$$\nFinally, we solve for $t_{\\mathrm{GVBD}}$ by dividing by $-k$:\n$$\nt_{\\mathrm{GVBD}} = -\\frac{1}{k} \\ln\\left(\\frac{c_{\\mathrm{thr}}}{c_0}\\right)\n$$\nThis expression can be simplified using the logarithmic identity $-\\ln(x) = \\ln(1/x)$. Applying this identity, we get:\n$$\nt_{\\mathrm{GVBD}} = \\frac{1}{k} \\ln\\left(\\left(\\frac{c_{\\mathrm{thr}}}{c_0}\\right)^{-1}\\right) = \\frac{1}{k} \\ln\\left(\\frac{c_0}{c_{\\mathrm{thr}}}\\right)\n$$\nThis is the closed-form analytic expression for the time to germinal vesicle breakdown. The problem specifies that $k$ is in units of $\\text{min}^{-1}$, so $1/k$ has units of minutes. The argument of the logarithm, $c_0/c_{\\mathrm{thr}}$, is a dimensionless ratio of concentrations. Thus, $t_{\\mathrm{GVBD}}$ is correctly expressed in minutes. The condition $0 < c_{\\mathrm{thr}} < c_0$ ensures that the ratio $c_0/c_{\\mathrm{thr}}$ is greater than $1$, so its natural logarithm is a positive value. Since $k$ is a rate constant, it is also positive, guaranteeing that $t_{\\mathrm{GVBD}} > 0$, which is physically required.",
            "answer": "$$\n\\boxed{\\frac{1}{k} \\ln\\left(\\frac{c_0}{c_{\\mathrm{thr}}}\\right)}\n$$"
        },
        {
            "introduction": "After ovulation, the newly formed corpus luteum assumes the vital role of producing progesterone, the primary hormone for preparing and maintaining the endometrium for a potential pregnancy. The circulating level of this hormone is not determined by production alone; it represents a dynamic equilibrium between synthesis and metabolic clearance. This practice employs a classic pharmacokinetic model to determine the steady-state serum progesterone concentration, providing a quantitative link between the endocrine output of the corpus luteum and its measurable systemic effect. ",
            "id": "4481808",
            "problem": "A patient on cycle day $21$ (mid-luteal phase) has a corpus luteum whose progesterone output is stimulated by Luteinizing Hormone (LH). Assume systemic progesterone behaves as a single well-stirred compartment with linear elimination characterized by the metabolic clearance rate $M$ (metabolic clearance rate is defined as the volume of serum cleared of the substance per unit time). Let the corpus luteum progesterone production rate $P(L)$ be a saturable function of the prevailing serum LH concentration $L$ given by a maximal production rate $P_{\\max}$ and a half-saturation constant $K_{L}$, so that\n$$\nP(L) = P_{\\max}\\,\\frac{L}{K_{L}+L}\n$$.\nAssume steady-state over the timescale of interest. Using the principle of mass conservation for a single compartment with linear clearance and the definition of metabolic clearance rate, derive the steady-state serum concentration of progesterone $C_{\\text{prog}}$ and compute its numerical value for the following physiologically plausible parameters:\n- $P_{\\max} = 25\\,\\text{mg day}^{-1}$,\n- $K_{L} = 1\\,\\text{IU L}^{-1}$,\n- $L = 2\\,\\text{IU L}^{-1}$,\n- $M = 1500\\,\\text{L day}^{-1}$,\n- progesterone molecular weight $MW_{\\text{prog}} = 314.46\\,\\text{g mol}^{-1}$.\nExpress the final concentration in $\\text{nmol L}^{-1}$ and round your answer to four significant figures.",
            "solution": "The problem as stated is scientifically grounded, well-posed, and contains all necessary information for a unique solution. The model described—a single-compartment pharmacokinetic system with saturable production and linear first-order elimination—is a standard and appropriate framework for this physiological context. The provided parameters are within plausible ranges for the human menstrual cycle. Therefore, the problem is valid, and we may proceed with the derivation and solution.\n\nThe fundamental principle governing the steady-state concentration of a substance in a single, well-stirred compartment is mass conservation. At steady-state, the rate of production (Rate In) of the substance must be equal to its rate of elimination (Rate Out).\n\n$$\n\\text{Rate In} = \\text{Rate Out}\n$$\n\nThe rate of progesterone production by the corpus luteum, $P(L)$, is given as a function of the luteinizing hormone ($LH$) concentration, $L$. This rate represents the mass of progesterone entering the systemic circulation per unit time. The function is:\n$$\n\\text{Rate In} = P(L) = P_{\\max}\\,\\frac{L}{K_{L}+L}\n$$\nThe units of this rate are mass per time, specifically $\\text{mg day}^{-1}$.\n\nThe rate of elimination is characterized by the metabolic clearance rate, $M$. The metabolic clearance rate is defined as the volume of serum cleared of the substance per unit time (e.g., $\\text{L day}^{-1}$). For a substance with a serum concentration $C_{\\text{prog}}$, the total rate of elimination is the product of the clearance rate and the concentration. This assumes linear elimination kinetics.\n$$\n\\text{Rate Out} = M \\times C_{\\text{prog}}\n$$\nFor the units to be consistent, if $M$ is in $\\text{L day}^{-1}$ and $C_{\\text{prog}}$ is in $\\text{mg L}^{-1}$, the Rate Out will be in $\\text{mg day}^{-1}$, matching the Rate In.\n\nAt steady-state, we equate the two rates:\n$$\nP_{\\max}\\,\\frac{L}{K_{L}+L} = M \\times C_{\\text{prog}}\n$$\n\nWe are tasked with deriving the steady-state serum concentration of progesterone, $C_{\\text{prog}}$. We can rearrange the above equation to solve for $C_{\\text{prog}}$:\n$$\nC_{\\text{prog}} = \\frac{1}{M} \\left( P_{\\max}\\,\\frac{L}{K_{L}+L} \\right)\n$$\nThis is the symbolic expression for the steady-state progesterone concentration.\n\nNow, we substitute the provided numerical values into this expression:\n- $P_{\\max} = 25\\,\\text{mg day}^{-1}$\n- $K_{L} = 1\\,\\text{IU L}^{-1}$\n- $L = 2\\,\\text{IU L}^{-1}$\n- $M = 1500\\,\\text{L day}^{-1}$\n\nFirst, we calculate the production rate, $P(L)$:\n$$\nP(L) = (25\\,\\text{mg day}^{-1}) \\times \\frac{2\\,\\text{IU L}^{-1}}{1\\,\\text{IU L}^{-1} + 2\\,\\text{IU L}^{-1}} = 25 \\times \\frac{2}{3}\\,\\text{mg day}^{-1} = \\frac{50}{3}\\,\\text{mg day}^{-1}\n$$\n\nNext, we use this production rate to calculate the mass concentration of progesterone:\n$$\nC_{\\text{prog}} = \\frac{P(L)}{M} = \\frac{\\frac{50}{3}\\,\\text{mg day}^{-1}}{1500\\,\\text{L day}^{-1}} = \\frac{50}{3 \\times 1500}\\,\\text{mg L}^{-1} = \\frac{50}{4500}\\,\\text{mg L}^{-1} = \\frac{1}{90}\\,\\text{mg L}^{-1}\n$$\n\nThe problem requires the final answer to be expressed in units of nanomoles per liter ($\\text{nmol L}^{-1}$). To perform this conversion, we use the molecular weight of progesterone, $MW_{\\text{prog}} = 314.46\\,\\text{g mol}^{-1}$.\n\nFirst, convert the mass concentration from $\\text{mg L}^{-1}$ to $\\text{g L}^{-1}$:\n$$\nC_{\\text{prog}} = \\frac{1}{90}\\,\\text{mg L}^{-1} \\times \\frac{1\\,\\text{g}}{1000\\,\\text{mg}} = \\frac{1}{90000}\\,\\text{g L}^{-1}\n$$\n\nNext, convert the mass concentration ($\\text{g L}^{-1}$) to molar concentration ($\\text{mol L}^{-1}$) by dividing by the molecular weight ($MW_{\\text{prog}}$):\n$$\nC_{\\text{prog}} (\\text{mol L}^{-1}) = \\frac{C_{\\text{prog}} (\\text{g L}^{-1})}{MW_{\\text{prog}} (\\text{g mol}^{-1})} = \\frac{\\frac{1}{90000}\\,\\text{g L}^{-1}}{314.46\\,\\text{g mol}^{-1}} = \\frac{1}{90000 \\times 314.46}\\,\\text{mol L}^{-1}\n$$\n\nFinally, convert from $\\text{mol L}^{-1}$ to $\\text{nmol L}^{-1}$ using the conversion factor $1\\,\\text{mol} = 10^9\\,\\text{nmol}$:\n$$\nC_{\\text{prog}} (\\text{nmol L}^{-1}) = \\left(\\frac{1}{90000 \\times 314.46}\\right)\\,\\text{mol L}^{-1} \\times \\frac{10^9\\,\\text{nmol}}{1\\,\\text{mol}}\n$$\n$$\nC_{\\text{prog}} = \\frac{10^9}{9 \\times 10^4 \\times 314.46} = \\frac{10^5}{9 \\times 314.46} = \\frac{100000}{2830.14}\\,\\text{nmol L}^{-1}\n$$\n$$\nC_{\\text{prog}} \\approx 35.334005... \\,\\text{nmol L}^{-1}\n$$\n\nRounding the result to four significant figures as required gives:\n$$\nC_{\\text{prog}} = 35.33\\,\\text{nmol L}^{-1}\n$$",
            "answer": "$$\\boxed{35.33}$$"
        }
    ]
}